Ozempic is changing how Americans spend money, and the numbers are startling

Millions of Americans are spending potentially hundreds of dollars each month on GLP-1 medications, but that comes at a cost: Their weight-loss journey is shaking up how they spend their money. In the five years since these medications were approved for chronic weight management by the Food and Drug Administration, they’ve grown in popularity, such that an estimated 11% of American adults are now taking some form of a GLP-1 to lose weight. While that’s led to some very visible trends—say, the...